Meeder Asset Management Inc Cidara Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.74 - $4.26 $7,831 - $19,174	-4,501 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$1.25 - $2.35 $752 - $1,414	-602 Reduced 11.8%	4,501 $9,000
Q2 2019 Aug 05, 2019	BUY	$1.49 - $2.94 $3,282 - $6,476	2,203 Added 75.97%	5,103 $9,000
Q4 2018 Jan 17, 2019	BUY	$2.1 - $4.5 $808 - $1,732	385 Added 15.31%	2,900 $7,000
Q3 2018 Nov 02, 2018	BUY	$3.7 - $5.25 $5,283 - $7,497	1,428 Added 131.37%	2,515 $0
Q2 2018 Jul 24, 2018	BUY	$3.75 - $6.05 $1,245 - $2,008	332 Added 43.97%	1,087 $0
Q1 2018 May 03, 2018	BUY	$4.0 - $8.15 $304 - $619	76 Added 11.19%	755 $3,000
Q4 2017 Feb 02, 2018	SELL	$6.35 - $8.75 $2,025 - $2,791	-319 Reduced 31.96%	679 $5,000
Q3 2017 Oct 20, 2017	BUY	$5.75 - $8.1 $5,738 - $8,083	998	998 $8,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.23B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.